Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07924527

Predicting Benefit From Anthracycline-Free Adjuvant Chemotherapy in High-Risk HER2-Negative Breast Cancer

Sponsor: Peking Union Medical College Hospital

View on ClinicalTrials.gov

Summary

This is an observational cohort study. Investigators do not assign any intervention to participants. Chemotherapy was received in a completed clinical trial or is determined by the treating physicians as part of routine care, and study results will not be used to guide treatment. The study aims to identify clinicopathological and molecular features associated with outcomes after anthracycline-free or anthracycline-containing chemotherapy in women with high-risk, HER2-negative early breast cancer. Existing clinical and follow-up data and archived tumor tissue from participants of a trial completed at Peking Union Medical College Hospital (NCT01354522; enrollment ended in 2013) will be analyzed with gene expression, metabolic, and digital pathology methods to develop a prediction model. Tumor tissue remaining after routine surgery or biopsy will also be collected, with informed consent, from up to 50 additional patients for single-cell sequencing. All analyses are exploratory.

Official title: Individualized Anthracycline-Free Adjuvant Chemotherapy for High-Risk HER2-Negative Breast Cancer: Development of an Artificial Intelligence Prediction Model and Investigation of Metabolic Mechanisms Using Data and Archived Tissue From a Completed Clinical Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

100

Start Date

2026-05-01

Completion Date

2027-12-01

Last Updated

2026-11-09

Healthy Volunteers

No

Interventions

DRUG

Anthracycline-free chemotherapy

Received as part of routine clinical care or a previous trial; not assigned by this study.

DRUG

Anthracycline-containing chemotherapy

Received as part of routine clinical care or a previous trial; not assigned by this study.

Locations (1)

Peking union medical college hospital

Beijing, China, China